Clinical Trials

Showing trials with last updates posted in 2026.

NCT07564141 | RECRUITING | PHASE3
688 participants

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2026-08-28
Completion:
2029-12-31
Conditions
  • Platinum-Sensitive Ovarian Cancer
  • Ovarian Cancer
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT07504458 | RECRUITING | PHASE3
150 participants

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2026-06-08
Completion:
2027-03-31
Conditions
  • Acute Promyelocytic Leukemia (APL)
  • Acute Promyelocytic Leukaemia
  • Acute Promyelocytic Leukemia With PML-RARA
  • Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
  • Acute Promyelocytic Leukemia
Interventions
  • DRUG
No Results Yet
NCT07468071 | RECRUITING | PHASE1/PHASE2
40 participants

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2026-06-08
Completion:
2029-06-11
Conditions
  • Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer
  • Advanced Solid Tumors Harboring the KRAS G12C Mutation
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page